Skip to main content
. 2020 Dec 17;11:625830. doi: 10.3389/fphar.2020.625830

TABLE 4.

Adverse effect.

4 ml group 2 ml group 1 ml group p-Value a
Transient, %
 Minor symptoms b 45.0 20.0 23.8 0.180
 Neuropathic symptoms c 20.0 20.0 9.5 0.589
Severe complication d , % 0 0 0 1.000

D5W, 5% dextrose water.

a

Between-group comparison: chi-square test for categorical data analysis.

b

Minor symptoms included needling pain, subjective swelling or dizziness subsided within 10 min.

c

Neuropathic symptoms included electric shock sensation or finger numbness subsided within 10 min.

d

Severe complication included infection, persisted bleeding, hematoma or death.